Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01776151 · ClinicalTrials.gov registry record
Arterial Elasticity: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 337
- Enrollment target
NCT01776151: Completed study, sponsored by University of Minnesota.
NCT01776151 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 337 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01776151 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 337 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if starting anti-retroviral therapy (ART) above 500 cluster-of-differentiation-4 (CD4)+ cells/milliliter (mL) ('early ART group') is better at reducing the stiffness of arteries than waiting to start ART until the CD4+ drops below 350 cells/mL ('deferred ART group'). Artery stiffness has been associated with an increased risk of cardiovascular (heart) disease, and could be useful as an earlier indicator of heart disease. In this study, the stiffness of arteries will be measured at study entry, months 4, 8, 12, and annually thereafter, using a tonometer on the participant's forearm.
Primary Outcome
Large artery elasticity is measured using a tonometer placed on the forearm.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 337 participants |
| Start Date | 2009-04-15 |
| Est. Completion | 2015-09 |
What the finished NCT01776151 record still lists
NCT01776151 is an observational study that tracks outcomes without assigning an intervention. The registered 337 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01776151 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01776151 about?
NCT01776151 is a clinical study titled "Arterial Elasticity: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)". The purpose of this study is to find out if starting anti-retroviral therapy (ART) above 500 cluster-of-differentiation-4 (CD4)+ cells/milliliter (mL) ('early ART group') is better at reducing the stiffness of arteries than waiting to start ART until the CD4+ drops below 350 cells/mL ('deferred ART ...
What is the current status of trial NCT01776151?
This trial is currently completed. The enrollment target is 337 participants. The study started on 2009-04-15. Estimated completion is 2015-09.
Who is sponsoring clinical trial NCT01776151?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03253263 · 338 participants · Phase 2
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
- NCT05658731 · 338 participants · NA
Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
- NCT06022939 · 338 participants · Phase 3
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
- NCT03947385 · 336 participants · Phase 1
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI